Trabectedin (Ecteinascidin-743 or ET-743)是海洋来源的抗癌剂。
曲贝替定
qǔ bèi tì dìng
更新时间:2024-04-30 03:40:28
- 常用名曲贝替定英文名trabectedin
- CAS号114899-77-3分子量761.837
- 密度1.6±0.1 g/cm3沸点N/A
- 分子式C39H43N3O11S熔点N/A
- MSDS闪点N/A
- 符号信号词
曲贝替定 名称
- 中文名他比特啶
- 英文名trabectedin
- 中文别名他比特定 |曲贝替定 |
- 英文别名ecteinascidin-743 |(1R,1'R,2'R,3'R,11'S,12'S,14'R)-5',6,12'-Trihydroxy-6',7-dimethoxy-7',21',30'-trimethyl-27'-oxo-3,4-dihydro-2H-spiro[isoquinoline-1,26'-[17,19,28]trioxa[24]thia[13,30]diazaheptacyclo[12.9.6.1.0.0.0.0]triaconta[4,6,8,15,20,22]hexaen]-22'-yl acetate |ET-743 |Trabectedin |ecteinascidin 743 |(1'R,6R,6aR,7R,13S,14S,16R) |Ecteinascidine 743 |Ecteinascidin |ET743 |Yondelis(R) |UNII-ID0YZQ2TCP |5-(acetyloxy)-3',4',6,6a,7,13,14,16-octahydro-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-,[6R-(6a,6a3,73,133,143,16a,20R*)] |Yondelis |
曲贝替定 生物活性
- 描述Trabectedin (Ecteinascidin-743 or ET-743)是海洋来源的抗癌剂。
- 相关类别信号通路 >> 细胞凋亡 >> 细胞凋亡 天然产物 >> 生物碱 研究领域 >> 癌症
- 参考文献[1]. Takahashi N, et al. Sequence-dependent synergistic cytotoxicity of ecteinascidin-743 and paclitaxel in human breast cancer cell linesin vitro and in vivo. Cancer Res. 2002 Dec 1;62(23):6909-15. [2]. Atmaca H, et al. A diverse induction of apoptosis by trabectedin in MCF-7 (HER2-/ER+) and MDA-MB-453 (HER2+/ER-) breast cancer cells. Toxicol Lett. 2013 Jun 20;221(2):128-136. [3]. Germano G, et al. Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells. Cancer Res. 2010 Mar 15;70(6):2235-44. [4]. Sessa C, et al. Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours. Eur J Cancer. 2009 Aug;45(12):2116-22.
曲贝替定 物理化学性质
- 密度1.6±0.1 g/cm3
- 分子式C39H43N3O11S
- 分子量761.837
- 精确质量761.261841
- PSA194.02000
- LogP3.10
- 折射率1.732
曲贝替定 合成路线
共页
曲贝替定 上游产品
曲贝替定上游产品 0
曲贝替定 用途